Pharma firms pressed to tackle neglected diseases in developing worldEurActiv… progress has been made. But there’s still a lot to be done when it comes to policy making, particularly in low- and middle income countries." Next steps: 2020: WHO target … Continue reading 
from WordPress http://ift.tt/1g3VR2c
from WordPress http://ift.tt/1g3VR2c
No comments:
Post a Comment